{"disease":{"id":"adult-solid-tumor","name":"adult solid tumor"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06895681","title":"UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":50000,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT00477958","title":"Assessment Tool for Older Patients With Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1062,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT05216432","title":"First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":930,"lead_sponsor_name":"Relay Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03253575","title":"CANscriptTM Clinical Outcomes in a Real-World Setting (ANCERS)-2","phase":"","overall_status":"SUSPENDED","enrollment_count":800,"lead_sponsor_name":"Mitra RxDx, Inc.","has_results":false},{"nct_id":"NCT02568267","title":"Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":534,"lead_sponsor_name":"Hoffmann-La Roche","has_results":false},{"nct_id":"NCT01828775","title":"Palliative Care Intervention in Improving Quality of Life, Psychological Distress, and Communication in Patients With Solid Tumors Receiving Treatment","phase":"NA","overall_status":"COMPLETED","enrollment_count":480,"lead_sponsor_name":"City of Hope Medical Center","has_results":false},{"nct_id":"NCT02116530","title":"Antiemetic Therapy With or Without Olanzapine in Preventing Chemotherapy-Induced Nausea and Vomiting in Patients With Cancer Receiving Highly Emetogenic Chemotherapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":401,"lead_sponsor_name":"Alliance for Clinical Trials in Oncology","has_results":true},{"nct_id":"NCT00003816","title":"Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":361,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT04538625","title":"Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Cancer Therapy","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"Napo Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04537936","title":"Psychotherapy Intervention for Latinos With Adv Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":285,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT03760952","title":"Human Leukocyte Antigen Typing and Tumor Antigen Expression Profiling","phase":"","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"Immatics US, Inc.","has_results":false},{"nct_id":"NCT04942717","title":"Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values","phase":"NA","overall_status":"RECRUITING","enrollment_count":234,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT02270450","title":"S1316, Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction","phase":"NA","overall_status":"COMPLETED","enrollment_count":221,"lead_sponsor_name":"SWOG Cancer Research Network","has_results":true},{"nct_id":"NCT03303365","title":"Cyberknife Radiosurgery for Patients With Brain Metastases Diagnosed With Either SPACE or MPRAGE Sequence","phase":"NA","overall_status":"COMPLETED","enrollment_count":203,"lead_sponsor_name":"Juergen Debus","has_results":false},{"nct_id":"NCT06916442","title":"Granzyme B-targeted PET Imaging Monitoring Tumor Responses to Immunotherapy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Zhongnan Hospital","has_results":false},{"nct_id":"NCT04015609","title":"Psychotherapy Intervention for Latinos With Advanced Cancer","phase":"NA","overall_status":"RECRUITING","enrollment_count":190,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT00459134","title":"L-Arginine Supplements in Treating Women Who Are Cancer Survivors","phase":"NA","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":true},{"nct_id":"NCT00536601","title":"High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors","phase":"NA","overall_status":"COMPLETED","enrollment_count":174,"lead_sponsor_name":"Roswell Park Cancer Institute","has_results":true},{"nct_id":"NCT04705818","title":"Combining Epigenetic And Immune Therapy to Beat Cancer.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Institut Bergonié","has_results":false},{"nct_id":"NCT05481502","title":"An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors","phase":"NA","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Gustave Roussy, Cancer Campus, Grand Paris","has_results":false},{"nct_id":"NCT00070148","title":"Oxandrolone Compared With Megestrol in Preventing Weight Loss in Patients Receiving Chemotherapy for Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":155,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT06047379","title":"Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":134,"lead_sponsor_name":"Neonc Technologies, Inc.","has_results":false},{"nct_id":"NCT07246863","title":"Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":131,"lead_sponsor_name":"CatalYm GmbH","has_results":false},{"nct_id":"NCT05086692","title":"A Beta-only IL-2 ImmunoTherapY Study","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":115,"lead_sponsor_name":"Medicenna Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07098988","title":"Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLC","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":107,"lead_sponsor_name":"CatalYm GmbH","has_results":false},{"nct_id":"NCT01642342","title":"Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":102,"lead_sponsor_name":"University of Southern California","has_results":false},{"nct_id":"NCT00003687","title":"Treatment for Chronic Pain in Patients With Advanced Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":87,"lead_sponsor_name":"NCIC Clinical Trials Group","has_results":false},{"nct_id":"NCT04200963","title":"A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Ikena Oncology","has_results":false},{"nct_id":"NCT04443088","title":"An Open-Label Study of INV-1120 as a Single Agent and in Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":78,"lead_sponsor_name":"Shenzhen Ionova Life Sciences Co., Ltd.","has_results":false},{"nct_id":"NCT00712712","title":"Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Institut Bergonié","has_results":true},{"nct_id":"NCT04761198","title":"A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":76,"lead_sponsor_name":"Mereo BioPharma","has_results":true},{"nct_id":"NCT03382340","title":"IMX-110 in Patients With Advanced Solid Tumors","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":70,"lead_sponsor_name":"Immix Biopharma Australia Pty Ltd","has_results":false},{"nct_id":"NCT05147272","title":"Study of RP-6306 With Gemcitabine in Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":67,"lead_sponsor_name":"Debiopharm International SA","has_results":true},{"nct_id":"NCT05228015","title":"Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":67,"lead_sponsor_name":"Ikena Oncology","has_results":false},{"nct_id":"NCT00892385","title":"Methoxyamine and Temozolomide in Treating Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":66,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT05346484","title":"A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":66,"lead_sponsor_name":"Imugene Limited","has_results":false},{"nct_id":"NCT00711243","title":"Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":59,"lead_sponsor_name":"Northwestern University","has_results":true},{"nct_id":"NCT01791088","title":"Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"University of Chicago","has_results":false},{"nct_id":"NCT01791595","title":"A Phase I Trial of AZD3965 in Patients With Advanced Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"Cancer Research UK","has_results":true},{"nct_id":"NCT04474470","title":"A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":52,"lead_sponsor_name":"TyrNovo Ltd.","has_results":false},{"nct_id":"NCT00107250","title":"AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"NCIC Clinical Trials Group","has_results":false},{"nct_id":"NCT06277804","title":"A Phase I Study of LTC004 Combin With FC in Patients With Advanced/Metastatic Malignancies Tumor","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":48,"lead_sponsor_name":"Letolab","has_results":false},{"nct_id":"NCT00540982","title":"Vinorelbine in Treating Patients With Advanced Solid Tumors That Have Not Responded to Treatment and Liver Dysfunction","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":47,"lead_sponsor_name":"City of Hope Medical Center","has_results":true},{"nct_id":"NCT00486356","title":"Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"University of Nebraska","has_results":false},{"nct_id":"NCT02049593","title":"PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Jonsson Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT01042535","title":"Vaccine Therapy and 1-MT in Treating Patients With Metastatic Breast Cancer","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","has_results":true},{"nct_id":"NCT05759949","title":"First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Relay Therapeutics, Inc.","has_results":false},{"nct_id":"NCT00471432","title":"OGX-011 and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"NCIC Clinical Trials Group","has_results":false},{"nct_id":"NCT07226466","title":"Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT02116777","title":"Talazoparib and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":true}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}